To Top

Search By Topic

Pharma

72 Articles available
Duchenne Muscular Dystrophy

Fight Against Duchenne Muscular Dystrophy Gets Major Funding Boost

PR-M09-18-NI-063
NDA

Ortho Dermatologics Resubmits U.S. New Drug Application For DUOBRII™ (halobetasol propionate and tazarotene) Lotion

PR-M09-18-NI-057
Artificial Intelligence

WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies

PR-M09-18-NI-054
Pharma

Preparing for Hurricane Florence in Pharma

PAO-M09-18-NI-013
FDA Approval

Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease

PR-M09-18-NI-053
Study Results

Teva and Regeneron Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip

PR-M09-18-NI-051
Study Results

Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1

PR-M09-18-NI-045
Drug Designation

Martin Pharmaceuticals’ LIVANTRA™ Receives FDA Orphan Drug Designation in Second Indication

PR-M09-18-NI-033
Orphan Drug Designation

FDA Grants Orphan Drug Designation to Onspira Therapeutics' Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans

PR-M09-18-NI-032
Generics

Mylan Launches First Generic for Adcirca® Tablets

PR-M09-18-NI-021
FDA Approval

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection

PR-M09-18-NI-020
Regulatory

Regeneron Provides Regulatory Update on EYLEA® (aflibercept) Injection sBLA in Wet Age-Related Macular Degeneration

PR-M09-18-NI-016
Workforce

Grant Will Fund Workforce Development Program for Biopharma Industry

PAO-M09-18-NI-001
Logistics

LATAM Cargo Opens Pharma Hub in Denmark

PR-M09-18-NI-073
FDA Approval

FDA Grants Breakthrough Therapy Designation for Xolair(Omalizumab) for Food Allergies

PR-M09-18-NI-005
FDA Approval

TherapeuticsMD Announces FDA Approval of ANNOVERA™ (Segesterone Acetate/Ethinyl Estradiol Vaginal System) for Birth Control

PR-M09-18-NI-002
Clinical Data

Novartis Reports Promising Results for its New Alpha Specific PI3K Inhibitor BYL719

PAO-M08-18-NI-028
FDA Approval

Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-Muscle Invasive Bladder Cancer

PR-M08-18-NI-099
Regulatory

China to Accelerate Review of 48 Foreign Drugs

PAO-M08-18-NI-013
China

Big Pharma Companies Taking New Drugs to China First

PAO-M08-18-NI-010
Industry Trend

China Turning to Indian Drug Manufacturers in Response to Trade War with US

PAO-M07-18-NI-011
Legislation

“Right To Try” Now Legal Across State Lines

PAO-M05-18-NI-026
Controlled Nucleation

Achieving Controlled Nucleation During Aseptic Lyophilization

PAP-Q2-18-CL-018
Market Expansion

BioPharma CDMO Success Requires Technical Leadership and Problem-Solving Capabilities

PAP-Q2-18-CL-019
Certification

Merck KGaA, Darmstadt, Germany certified as one of the Top Employers North America 2018

PR-M02-18-NI-028
Cardiovascular

Secant Group Develops the First Synthetic Regenerative Cardiovascular Graft

PR-M01-18-NI-052
Research

Pfizer Establishes New Partnering Model for Early-Stage Academic Research

PR-M01-18-NI-023
Press Releases

Intec Pharma Announces Development Collaboration With Global Pharmaceutical Company

PR-M01-18-NI-019
Strategic Partnership

Mitochondrial Expert Mitobridge Snapped Up by Astellas Pharma

PAO-M01-18-NI-002
Innovation

PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry

PR-M12-17-NI-007
Regulatory

Booklet Label Combines Tamper-Protection And Drug Information

PR-M12-17-NI-004
Oncology

Holiday Program Brings Hope Home to Lung Cancer Patients

PR-M12-17-NI-002
Drug Development

U.S. Patient Receives Kite’s Yescarta CART-T Therapy

PAO-M12-17-NI-008
Medical Application

FDA Clears KardiaBand Apple Watch Heart Monitoring App

PAO-M12-17-NI-006
Mergers & Acquistions

Five Critical Considerations for Pharmaceutical M&A

PAO-M12-17-Cl-001
Recognition

Vetter receives Corporate Health Award’s recognition of excellence

PR-M12-17-NI-001
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

PAO-M12-17-NI-008
Strategic Partnership

Russia’s BIOCAD to Manufacture Biosimilars in North Africa

PAO-M12-17-NI-007
Cell and Gene Therapy

Brammer Bio Completes Renovations at Manufacturing Site in Massachusetts

PAO-M12-17-NI-006
Acquisition

Pharmaterials Acquired by Quotient Sciences

PAO-M11-17-NI-051
Research

Study Finds Less Teflon in Environment Leads to Less Brain Damage

PAO-M11-17-NI-052
Innovation

Single-Pill, HIV-1 Combination Therapy Approved

PAO-M11-17-NI-050
Discovery

Boehringer Ingelheim and HitGen Enter Drug Discovery Collaboration

PAO-M11-17-NI-049
Generics

Merger to Create Large US Generics Firm

PAO-M10-17-NI-042
Drug Pricing

California Moves to Increase Transparency of Prescription Drug Pricing

PAO-M10-17-NI-030
Supply Chain

IEEE Releases First Detailed Study of Blockchain Technology in Pharma

PAO-M10-17-NI-027
FDA Approval

Eli Lilly Gets Early Approval for Breast Cancer Drug

PAO-M10-17-NI-006
ADC

Pfizer Gets Second ADC Approval in 2017

PAO-M09-17-NI-019
Nice Insight Overview

Pharma Contract Services Consolidation Wave Continues

PAP-Q3-17-NO-001
Quality Management

Achieving a High Level of Customer Service Through Lean Quality Management

PAP-Q3-17-CL-001
Investment

Chinese Genetics Company Completes Successful IPO

PAO-M07-17-NI-032
FDA

Unjamming the Orphan Drug Backlog

PAO-M07-17-NI-009
FDA

FDA Moves to Improve Patient Access

PAO-M07-17-NI-004
Expansion

New Report Predicts Singapore Pharma Market Worth More Than $1 Billion by 2019

PAO-M06-17-NI-022
Pharma

Boston and San Francisco are the Top Biotech Clusters

PAO-M06-17-NI-007
Innovation

New Data May Lead to the Development of Drugs to Prevent Heart Problems in Diabetics

PAO-M06-17-NI-004
Pharma

Top Biotech Companies at Home in Ireland

PAO-M05-17-NI-035
Innovation

Pharma’s Back to Nature Trend

PAO-M05-17-NI-028
Pharma

First New ALS Treatment in Decades Approved by FDA

PAO-M05-17-NI-015
Innovation

Medical Cannabis Continues to Cultivate Innovation

PAO-M04-17-NI-028
Pharma

First On-Label Abuse-Deterrent Opioid Approved

PAO-M04-17-NI-026
Pharma

TRULANCE Gets Veteran to Pilot IBS Therapy Launch

PAO-M04-17-NI-024
Discovery

Novartis CAR-T Cell Therapy Receives Breakthrough Therapy Designation

PAO-M04-17-NI-025
CDMO

Pharma’s Renaissance Continues

PAP-Q03-16-ED-001